Skip to main content
. 2022 Feb 7;12:791983. doi: 10.3389/fimmu.2021.791983

Table 3.

Prevalence of hyperuricemia among adults in mainland China by risk factors and major chronic diseases, 2015-16 and 2018-19*.

Characteristics Prevalence, 95% CI
Men Women Overall
2015-16 2018-19 Changes of prevalence, 2018-19 vs 2015-16 2015-16 2018-19 Changes of prevalence, 2018-19 vs 2015-16 2015-16 2018-19 Changes of Prevalence, 2018-19 vs 2015-16
Current smoking
 Yes 18.4(17.2,19.7) 22.7(21.3,24.1) 4.3(3.5,5.0) 3.7(2.7,4.7) 3.7(2.7,4.7) 0.0(-0.7,1.0) 17.9(16.7,19.0) 21.9(20.6,23.3) 4.1(3.4,4.8)
 No 20.3(18.5,22.1) 26.2(24.2,28.1) 5.9(4.9,6.8) 2.8(2.5,3.0) 3.6(3.2,4.0) 0.9(0.6,0.0) 8.5(7.9,9.2) 13.0(12.2,13.8) 2.7(2.3,3.1)
 P for difference 0.0047 <0.0001 0.0436 0.8691 <0.0001 <0.0001
Heavy drinking
 Yes 22.5(19.5,25.6) 26.2(24.2,28.2) 3.7(2.0,5.4) 3.4(2.5,4.2) 5.5(3.5,7.5) 2.2(1.0,0.1) 18.5(16.2,20.7) 24.8(23.0,26.6) 6.3(5.0,7.7)
 No 18.5(17.4,19.7) 24.1(22.7,25.6) 5.6(4.9,6.3) 2.7(2.5,3.0) 3.6(3.2,4.0) 0.9(0.6,0.0) 10.0(9.4,10.6) 13.0(12.2,13.8) 3.0(2.6,3.4)
P for difference <0.0001 <0.0001 0.1588 0.0309 <0.0001 <0.0001
Beer drinking
 Never 17.9(17.0,18.9) 23.0(21.6,24.4) 5.1(4.3,5.9) 2.8(2.6,3.1) 3.7(3.3,4.1) 0.9(0.6,1.1) 9.0(8.5,9.4) 11.9(11.1,12.6) 2.9(2.4,3.3)
 At least once/year 20.5(17.9,23.1) 26.0(23.5,28.5) 5.5(4.2,6.9) 2.0(1.5,2.6) 2.8(2.0,3.5) 0.7(0.2,1.2) 15.6(13.6,17.6) 19.3(17.4,21.1) 3.7(2.7,4.6)
 At least once/week 23.1(19.9,26.2) 29.2(26.7,31.8) 6.2(4.4,7.9) 4.7(2.1,7.2) 3.7(2.1,5.3) -1.0(-2.6,0.6) 21.5(18.5,24.4) 27.1(24.8,29.4) 5.6(4.0,7.3)
 P for trend <0.0001 <0.0001 0.9621 0.1290 <0.0001 <0.0001
Fruit & vegetable intake <400g/d
 Yes 18.8(17.6,20.0) 25.1(22.8,27.4) 6.3(5.2,7.4) 2.9(2.6,3.3) 3.3(3.0,3.7) 0.4(0.2,0.7) 11.0(10.2,11.7) 14.4(13.1,15.7) 3.4(2.8,4.1)
 No 19.9(18.1,21.7) 23.9(22.6,25.1) 4.0(3.1,4.9) 2.6(2.4,2.9) 3.8(3.3,4.3) 1.2(0.9,1.5) 11.2(10.3,12.1) 13.6(12.9,14.4) 2.4(2.0,2.9)
 P for difference 0.1026 0.33 0.1077 0.1112 0.5070 0.2584
Red meat intake >100g/d
 Yes 23.2(21.7,24.7) 29.2(27.3,31.1) 6.0(5.2,6.8) 2.9(2.6,3.3) 4.7(3.8,5.5) 1.7(1.1,2.2) 15.3(14.4,16.2) 19.0(17.6,20.5) 3.7(3.1,4.4)
 No 17.3(16.0,18.7) 19.8(18.3,21.3) 2.5(1.5,3.5) 2.6(2.4,2.9) 3.0(2.7,3.4) 0.3(0.1,0.5) 10.7(9.9,11.5) 13.3(12.4,14.1) 0.9(0.4,1.4)
P for difference <0.0001 <0.0001 0.2911 <0.0001 <0.0001 <0.0001
Physical inactivity (<150min/w)
 Yes 20.0(18.5,21.6) 26.1(24.0,28.2) 6.1(4.9,7.3) 3.0(2.5,3.6) 4.6(3.8,5.3) 0.7(0.4,1.0) 12.5(11.5,13.4) 16.4(15.0,17.7) 3.9(3.1,4.7)
 No 19.1(17.5,20.8) 23.9(22.4,25.3) 4.8(4.0,5.5) 2.7(2.5,2.9) 3.4(3.0,3.8) 1.3(0.9,1.8) 10.7(9.9,11.5) 13.3(12.4,14.1) 2.6(2.2,3.0)
 P for difference 0.3864 0.0349 0.0372 0.0021 0.0018 <0.0001
BMI group (kg/m2)
 <18.5 9.8(7.2,12.3) 17.5(11.1,23.8) 7.7(3.5,11.9) 1.4(0.9,1.8) 0.8(0.4,1.2) -0.6(-0.9,-0.2) 5.2(4.1,6.4) 8.4(5.0,11.8) 3.2(1.1,5.3)
 18.5-24.9 14.6(12.8,16.4) 17.6(16.3,18.9) 3.0(2.1,3.8) 1.9(1.6,2.1) 2.4(2.1,2.7) 0.5(0.3,0.7) 8.0(7.1,9.0) 9.5(8.8,10.2) 1.4(1.0,1.8)
 25.0-29.9 25.4(23.7,27.2) 29.8(28.0,31.5) 4.3(3.3,5.4) 3.6(3.1,4.0) 5.0(4.3,5.8) 1.5(1.0,1.9) 15.4(14.3,16.4) 18.5(17.4,19.7) 3.2(2.5,3.8)
 ≥30.0 35.8(33.3,38.2) 46.9(43.0,50.7) 11.1(8.7,13.5) 9.1(7.8,10.4) 10.0(8.1,11.8) 0.9(-0.3,2.1) 22.6(21.3,24.0) 30.1(27.4,32.9) 7.5(5.9,9.1)
 P for trend <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Central obesity
 Yes 27.4(25.6,29.1) 33.4(31.5,35.3) 6.0(4.9,7.2) 5.0(4.6,5.5) 6.1(5.4,6.9) 1.1(0.7,1.6) 16.5(15.5,17.5) 20.5(19.2,21.8) 4.0(3.3,4.7)
 No 15.9(14.3,17.4) 19.1(17.6,20.7) 3.3(2.5,4.0) 1.9(1.6,2.1) 2.4(2.0,2.7) 0.5(0.3,0.7) 8.8(8.0,9.6) 10.5(9.6,11.3) 1.6(1.2,2.0)
 P for difference <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Hypertension
 Yes 22.1(20.7,23.5) 27.0(25.5,28.5) 4.9(3.9,5.8) 4.8(4.3,5.3) 6.3(5.5,7.0) 1.5(1.0,1.9) 14.2(13.3,15.0) 17.8(16.8,18.8) 3.6(3.0,4.3)
 No 18.0(16.4,19.7) 23.3(21.7,24.9) 5.3(4.5,6.1) 2.0(1.8,2.3) 2.8(2.4,3.2) 0.7(0.5,1.0) 10.6(9.9,11.4) 12.5(11.6,13.5) 2.7(2.3,3.1)
P for difference <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Diabetes status
 Normal NA 24.1(22.5,25.7) NA NA 2.6(2.3,3.0) NA NA 12.9(12.0,13.8) NA
 Prediabetes NA 26.9(24.9,29.0) NA NA 5.6(4.7,6.5) NA NA 17.2(15.8,18.5) NA
 Diabetes without treatment NA 26.0(23.6,28.4) NA NA 7.3(6.2,8.4) NA NA 18.2(16.6,19.7) NA
 Diabetes treated NA 16.8(14.3,19.4) NA NA 6.9(5.9,8.0) NA NA 11.7(10.1,13.2) NA
P for difference <0.0001 <0.0001 <0.0001
Low eGFR
 Yes NA 52.6(49.3,56.0) NA NA 25.3(22.6,28.0) NA NA 38.0(35.7,40.3) NA
 No NA 23.8(22.4,25.3) NA NA 3.1(2.7,3.4) NA NA 13.4(12.6,14.3) NA
P for difference <0.0001 <0.0001 <0.0001
Albuminuria
 Yes NA 31.4(28.7,34.1) NA NA 6.8(5.9,7.7) NA NA 18.5(16.8,20.2) NA
 No NA 23.9(22.6,25.3) NA NA 3.4(3.0,3.8) NA NA 13.8(12.9,14.6) NA
P for difference <0.0001 <0.0001 <0.0001
High TC
 Yes 30.3(27.3,33.2) 36.2(32.4,39.9) 5.9(4.1,7.7) 6.5(5.4,7.6) 8.9(7.1,10.7) 2.4(1.2,3.5) 17.9(16.5,19.2) 22.7(20.4,25.1) 4.9(3.7,6.0)
 No 18.7(17.3,20.0) 23.3(22.0,24.7) 4.7(3.9,5.4) 2.5(2.3,2.8) 3.1(2.8,3.5) 0.6(0.4,0.8) 10.6(9.9,11.4) 13.2(12.4,13.9) 2.5(2.1,2.9)
P for difference <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
High TG
 Yes 34.1(32.3,35.9) 40.7(38.4,43.1) 6.6(5.2,8.0) 8.5(7.4,9.6) 8.8(7.7,9.8) 0.3(-0.5,1.1) 24.6(23.4,25.8) 29.3(27.4,31.1) 4.6(3.6,5.7)
 No 15.9(14.3,17.5) 19.4(18.1,20.7) 3.5(2.7,4.2) 2.1(1.9,2.2) 2.8(2.5,3.2) 0.8(0.5,1.0) 8.7(7.9,9.5) 10.5(9.8,11.3) 1.8(1.5,2.2)
P for difference <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001

*Data are presented incorporating sample weights and adjusted for clusters and strata of the complex sample design of CCDRFS. P values for changes from 2015-16 to 2018-19 are <0.05. 95% CI, 95% confidence interval. NA, data not available; BMI, body mass index; TC, total cholesterol; TG, triglycerides; eGFR, estimated glomerular filtration rate.